What's Happening?
Three leading national Parkinson's advocacy organizations are urging Congress to increase funding for Parkinson's research at the National Institutes of Health (NIH) as part of the federal budget for Fiscal Year 2027. This call comes in response to a proposed
$5 billion reduction in NIH funding, which the groups argue would hinder scientific progress crucial for the 1.2 million Americans living with Parkinson's disease. The American Parkinson Disease Association, The Michael J. Fox Foundation for Parkinson's Research, and The Parkinson's Foundation are advocating for an annual federal investment of $600 million in Parkinson's research. This amount is less than 1% of the $82.2 billion annual economic burden of the disease. The organizations emphasize the importance of continued bipartisan support for NIH funding, which has historically driven significant advancements in Parkinson's treatment and research.
Why It's Important?
The proposed budget cuts to the NIH could significantly impact the pace of research and development of new treatments for Parkinson's disease and other neurodegenerative conditions. Increased funding is crucial not only for advancing scientific understanding but also for developing therapies that could improve the quality of life for millions of Americans. The advocacy groups highlight that federal investment has historically led to breakthroughs that benefit a wide range of neurodegenerative diseases, suggesting that continued funding could accelerate discoveries with broad implications. The call for increased funding is supported by a national survey indicating that a majority of voters favor doubling federal investment in Parkinson's research, reflecting public support for maintaining robust research funding.
What's Next?
The advocacy groups have mobilized over 300 Parkinson's advocates from across the United States to engage with their congressional representatives, sharing personal stories to underscore the urgency of increased research funding. As Congress deliberates the federal budget, these efforts aim to influence lawmakers to prioritize NIH funding in the appropriations process. The outcome of these discussions will determine the level of federal support for Parkinson's research in the coming fiscal year, impacting the trajectory of scientific progress and potential treatment breakthroughs.
